Sfoglia per SSD
2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
2016 M.F. Piepoli, A.W. Hoes, S. Agewall, C. Albus, C. Brotons, A.L. Catapano, M. Cooney, U. Corrà, B. Cosyns, C. Deaton, I. Graham, M.S. Hall, F.D..R. Hobbs, M. Løchen, H. Löllgen, P. Marques Vidal, J. Perk, E. Prescott, J. Redon, D.J. Richter, N. Sattar, Y. Smulders, M. Tiberi, H. Bart van der Worp, I. van Dis, W.M.M. Verschuren, M. Piepoli
2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia
2018 U. Landmesser, M.J. Chapman, J.K. Stock, P. Amarenco, J.J.F. Belch, J. Borén, M. Farnier, B.A. Ference, S. Gielen, I. Graham, D.E. Grobbee, G.K. Hovingh, T.F. Lüscher, M.F. Piepoli, K.K. Ray, E.S. Stroes, O. Wiklund, S. Windecker, J.L. Zamorano, F. Pinto, L. Tokgözoǧlu, J.J. Bax, A.L. Catapano
2019 ESC/EAS guidelines for the management of dyslipidaemias : Lipid modification to reduce cardiovascular risk
2019 F. Mach, C. Baigent, A.L. Catapano, K.C. Koskina, M. Casula, L. Badimon, M.J. Chapman, G.G. De Backer, V. Delgado, B.A. Ference, I.M. Graham, A. Halliday, U. Landmesser, B. Mihaylova, T.R. Pedersen, G. Riccardi, D.J. Richter, M.S. Sabatine, M.-. Taskinen, L. Tokgozoglu, O. Wiklund, S. Windecker, V. Aboyans, J.-. Collet, V. Dean, D. Fitzsimons, C.P. Gale, D. Grobbee, S. Halvorsen, G. Hindricks, B. Iung, P. Juni, H.A. Katus, C. Leclercq, M. Lettino, B.S. Lewis, B. Merkely, C. Mueller, S. Petersen, A.S. Petronio, M. Roffi, E. Shlyakhto, I.A. Simpson, M. Sousa-Uva, R.M. Touyz, D. Nibouche, P.H. Zelveian, P. Siostrzonek, R. Najafov, P. van de Borne, B. Pojskic, A. Postadzhiyan, L. Kypris, J. Spinar, M.L. Larsen, H.S. Eldin, M. Viigimaa, T.E. Strandberg, J. Ferrieres, R. Agladze, U. Laufs, L. Rallidis, L. Bajnok, T. Gudjonsson, V. Maher, Y. Henkin, M.M. Gulizia, A. Mussagaliyeva, G. Bajraktari, A. Kerimkulova, G. Latkovskis, O. Hamoui, R. Slapikas, L. Visser, P. Dingli, V. Ivanov, A. Boskovic, M. Nazzi, F. Visseren, I. Mitevska, K. Retterstol, P. Jankowski, R. Fontes-Carvalho, D. Gaita, M. Ezhov, M. Foscoli, V. Giga, D. Pella, Z. Fras, L. Perez de Isla, E. Hagstrom, R. Lehmann, L. Abid, O. Ozdogan, O. Mitchenko, R.S. Patel
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
2020 F. Mach, C. Baigent, A.L. Catapano, K.C. Koskinas, M. Casula, L. Badimon, M.J. Chapman, G.G. De Backer, V. Delgado, B.A. Ference, I.M. Graham, A. Halliday, U. Landmesser, B. Mihaylova, T.R. Pedersen, G. Riccardi, D.J. Richter, M.S. Sabatine, M.-. Taskinen, L. Tokgozoglu, O. Wiklund
27-Hydroxycholesterol modulation of low density lipoprotein metabolism in cultured human hepatic and extrahepatic cells
1993 S. Bellosta, A. Corsini, F. Bernini, A. Granata, G. Didoni, M. Mazzotti, R. Fumagalli
2β-3,4-Unsaturated sialic acid derivatives: Synthesis optimization, and biological evaluation as Newcastle disease virus hemagglutinin-neuraminidase inhibitors
2020 P. La Rocca, P. Rota, M. Piccoli, F. Cirillo, A. Ghiroldi, V. Franco, P. Allevi, L. Anastasia
The 3' untranslated region of human cyclin-dependent kinase 5 regulatory subunit 1 contains regulatory elements affecting transcript stability
2007 S. Moncini, A. Bevilacqua, M. Venturin, C. Fallini, A. Ratti, A. Nicolin, P. Riva
3' UTR (AGG)n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia
2004 A. Michelato, C. Bonvicini, M. Ventriglia, C. Scassellati, R. Randazzo, S. Bignotti, R. Beneduce, M.A. Riva, M. Gennarelli
3,4 methylenedioxymethamphetamine (ecstasy) impairs eight-arm radial maze performance and arm entry pattern in rats
2002 D. Braida, M. Pozzi, R. Cavallini, M. Sala
3,4 Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system
2005 D Braida, S Iosue, S Pegorini, M Sala
3-Aryl-N-aminoylsulfonylphenyl-1H-pyrazole-5-carboxamides : a new class of selective Rac inhibitors
2013 N. Ferri, S.K. Bernini, A. Corsini, F. Clerici, E. Erba, S. Stragliotto, A. Contini
3-Hydroxy-3-methylglutaric acid (HMGA) reduces dietary cholesterol induction of saturated bile in hamster
1982 C. Di Padova, E. Bosisio, G. Cighetti, P. Rovagnati, M. Mazzocchi, C. Colombo, R. Tritapepe
3-Methoxytyramine and different neuroleptics: Dissociation from HVA and DOPAC
1978 A. Groppetti, M. Parenti, C.L. Galli, A. Bugatti, F. Cattabeni, A.M. Di Giulio, G. Racagni
3. Symposium of cellular biology of epithelia : atti del convegno (6 novembre 2006)
2008 E.B. Donetti, N. Gagliano, C. Sforza
A 33-year-old man with nephrotic syndrome and lecithin-cholesterol acyltransferase (LCAT) deficiency. Description of two new mutations in the LCAT gene
2004 G.M. Frasca, L. Soverini, E. Tampieri, G. Franceschini, L. Calabresi, L. Pisciotta, P. Preda, A. Vangelista, S. Stefoni, S. Bertolini
-374 T/A RAGE Polymorphism Is Associated with Chronic Kidney Disease Progression in Subjects Affected by Nephrocardiovascular Disease
2013 I. Baragetti, G.D. Norata, C. Sarcina, A. Baragetti, F. Rastelli, L. Buzzi, L. Grigore, K. Garlaschelli, C. Pozzi, A.L. Catapano
3D mesoporous bioactive glass/silk/chitosan scaffolds and their compatibility with human adipose-derived stromal cells
2020 R. Phetnin, S. Suksaweang, C. Giannasi, A.T.M. Brini, S. Niada, S. Arisuwan, S. Tubsungnoen Rattanachan
3D Printed Vascularized Device for Subcutaneous Transplantation of Human Islets
2017 M. Farina, A. Ballerini, D.W. Fraga, E. Nicolov, M. Hogan, D. Demarchi, F. Scaglione, O.M. Sabek, P. Horner, U. Thekkedath, O.A. Gaber, A. Grattoni
4-oxystilbene compounds are selective ligands for neuronal nicotinic alpha Bungarotoxin receptors
1998 C. Gotti, B. Balestra, M. Moretti, G. Rovati, L. Maggi, G. Rossoni, F. Berti, L. Villa, M. Pallavicini, F. Clementi
5-(2-Pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes: Synthesis of all the stereoisomers and α4β2 nicotinic affinity
2009 M. Pallavicini, C. Bolchi, M. Binda, A. Cilia, F. Clementi, R. Ferrara, L. Fumagalli, C. Gotti, M. Moretti, A. Pedretti, G. Vistoli, E. Valoti
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile